Abstract | OBJECTIVE: METHODS: RESULTS: Within 6 months after the injection, the total pain relief rate was 70.6% (89/126), including 25 (19.8%) cases with pain vanished, suggesting significant alleviation of the pain intensity by the treatment (u=5.361, P<0.01). The frequency of pain was reduced in 78.6% (99/126) of the cases (u=4.589, P<0.01), and the average score of pain decreased significantly from 7.54+/-3.29 to 4.19+/-4.38 (t=6.865, P<0.001). The number and size of lesions decreased by more than 25% in 57 cases, showing a total efficacy rate of 45.2% (57/126). No significant difference was noted in the therapeutic effects among the 4 pathological types of lung cancer (P>0.05). CONCLUSIONS:
|
Authors | Hang Zheng, Rong-cheng Luo, Yi-xiang Fan |
Journal | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
(Di Yi Jun Yi Da Xue Xue Bao)
Vol. 24
Issue 10
Pg. 1194-6
(Oct 2004)
ISSN: 1000-2588 [Print] China |
PMID | 15485798
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adenocarcinoma
(pathology, radiotherapy, secondary)
- Adult
- Aged
- Bone Neoplasms
(radiotherapy, secondary)
- Carcinoma, Squamous Cell
(pathology, radiotherapy, secondary)
- Female
- Humans
- Lung Neoplasms
(pathology, radiotherapy)
- Male
- Middle Aged
- Pain, Intractable
(radiotherapy)
- Strontium Radioisotopes
(therapeutic use)
|